Other

Institut Pasteur

Centre Nationale De La Recherche Scientifique

Olivier Ardouin

Christine Petit

Jean-Claude Mazie

Jean-Pierre Hardelin

Genevieve Rougon

Renaud Legouis

Nadia Soussi-Yanticostas

Catherine Sarailh

KAL protein is identified the active agent in a therapeutic composition for treatment of injury to nerve tissue, including spinal cord tissue, as well as support of treatment for renal grafts. Additionally, therapeutic treatment of renal injury, and kidney transplantation and renal surgery, is effected by administration of KAL protein. The therapeutic agent may be administered locally, or intravenously. Retinal disorders may be similarly treated.

Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury

KAL protein is identified as the active agent in a therapeutic composition for treatment of injury to nerve tissue, including spinal cord tissue, as well as support of treatment for renal grafts. Additionally, therapeutic treatment of renal injury, and kidney transplantation and renal surgery, is effected by administration of KAL protein. The therapeutic agent may be administered locally, or intravenously. Retinal disorders may be similarly treated.

Use of the KAL protein and treatment with the KAL protein in treatment

Growing community of inventors

Issy les Moulineaux, France

Olivier Ardouin